-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

732.P1.52 732. Allogeneic Transplantation: Disease Response and Comparative Treatment Studies: Poster I

Symposia: Allogeneic Transplantation: Disease Response and Comparative Treatment Studies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 10, 2022: 5:30 PM-7:30 PM
Hall D (Ernest N. Morial Convention Center)

Scott R. Solomon, MD1, Lizamarie Bachier-Rodriguez, MD1*, Xu Zhang, PhD2*, Michael T Aubrey3*, Christina L Roark3*, Lawrence E. Morris Jr., MD1*, H. Kent Holland, MD1, Asad Bashey, MD, PhD1 and Melhem Solh, MD1

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
2Center for Clinical and Transitional Sciences, University of Texas Health Science Center, Houston, TX
3University of Colorado Cord Blood Bank & Clinimmune Laboratory, Aurora, CO

Razan Mohty, MD1,2, Yenny Moreno Vanegas, MD, BSc1, Michael G. Heckman, MS3*, Hassan B. Alkhateeb, MD4*, Alexander P. Hochwald3*, William J. Hogan, MB, BCh4, Mohamed A. Kharfan-Dabaja, MD, MBA1, Rhett P. Ketterling, MD5*, Nandita Khera, MD, MPH6, Mark R. Litzow, MD4, Abhishek A. Mangaonkar, MBBS4, Hemant S. Murthy, MD1, Jeanne M. Palmer, MD6, Mithun V. Shah, MD, PhD4, Lisa Z. Sproat, MD6, David S. Viswanatha, MD5 and James M. Foran, MD1

1Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
2Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa
3Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL
4Division of Hematology, Mayo Clinic, Rochester, MN
5Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
6Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ

Franco Locatelli, Prof., MD, PhD1,2, Peter Bader, MD, PhD3, Jean-Hugues Dalle, MD, PhD4, Ulrike Poetschger, PhD5*, Herbert Pichler, MD6*, Petr Sedlacek, MD, PhD7*, Jochen Büchner, MD, PhD8*, Peter J Shaw, MD9*, Marianne Ifversen, MD, PhD10*, Raquel Staciuk, MD11*, Kim Vettenranta, MD, PhD12, Adriana Balduzzi, MD13 and Christina Peters, MD14*

1Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children's Hospital, Rome, Italy
2Catholic University of the Sacred Heart, Rome, Italy
3Department for Children and Adolescents, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, University Children's Hospital Frankfurt, Frankfurt, Germany
4Pediatric Hematology and Immunology Department, Robert Debré Hospital , GHU APHP Nord - Université Paris Cité, Paris, France
5Children's Cancer Research Institute, Vienna, Austria
6Children's Cancer Research Institute, St. Anna Children's Hospital, University Vienna, Vienna, Austria
7University Hospital Motol, Department of Paediatric Haematology And Oncology, Prague, Czech Republic
8Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo, Norway
9The Children's Hospital at Westmead, Sydney, AUS
10Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
11Hospital de Pediatría, Buenos Aires, Argentina
12Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland
13Bone Marrow Transplantation Unit, Clinica Pediatrica Università degli Studi di Milano-Bicocca, Fondazione MBBM, Monza, Italy
14Children’s Cancer Research Institute, 24509-58, Vienna, Austria

Amy E. DeZern, MD1, Marianna Zahurak, MS2*, Kenneth R. Cooke, MD3, Richard J. Jones, MD4 and Robert Brodsky, MD5

1Division of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
2Sidney Kimmel Comprehensive Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Sparks, MD
3Sidney Kimmel Comprehensive Cancer Center, The Sidney Kimmel Comp. Cancer Center At Johns Hopkins, Baltimore, MD
4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD
5Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD

Martina Calabrò, MD1*, Myriam Labopin, MD2,3,4*, Giorgia Battipaglia, MD1,5*, Mutlu Arat, MD6, Ibrahim Yakoub-Agha, MD, PhD7, Urpu Salmenniemi, MD8*, Jan Vydra, MD9*, Didier Blaise, MD, PhD10, Regis Peffault De Latour11*, Caroline Besley, FRCPath, PhD12*, Jean-Henri Bourhis, M.D.13, Renato Fanin, MD14*, Nicolaus Kröger, MD15*, Alessandro Rambaldi, MD16, Ben Carpenter17*, Péter Reményi, MD18*, Tobias Gedde-Dahl, MD19*, Sebastian Giebel, MD, PhD20*, Arnon Nagler, MD21, Fabio Ciceri, MD22* and Mohamad Mohty, MD PhD2,3,4

1Federico II University of Naples, Hematology Department, Naples, Italy
2Sorbonne Universités, UPMC Univ Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Paris, France
3EBMT Statistical Unit, Paris, France
4Hematology Department, Hôpital Saint Antoine, Service d'Hématologie Thérapie Cellulaire, Paris, France
5Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
6Hematopoietic SCT Unit, Demiroglu Bilim University Istanbul Florence Nightingale Hospital, Istanbul, Turkey
7CHU de Lille LIRIC, INSERM U995, Université de Lille, Lille, France
8Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
9Institute of Hematology and Blood Transfusion, Prague, Czech Republic
10Département d'hématologie, Programme de transplantation et de thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Aix-Marseille University, Institut Paoli Calmettes, Marseille, France
11Hopital St. Louis, Department of Hematology - BMT, Paris, France
12Bristol Royal Hospital for Children, Dept. of Paediatric Oncology/BMT, Bristol, United Kingdom
13Division of Hematology, Department of Medical Oncology, Gustave Roussy, institut de cancérologie, BMT Service, Villejuif, France
14Division of Hematology and BMT, Department of Medical Area, University of Udine, Udine, Italy
15University Medical Center Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany
16Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
17University College London Hospital, Department of Haematology, London, United Kingdom
18Dél-pesti Centrumkórház – Országos Hematológiai és Infektológiai Intézet, Dept. Haematology and Stem Cell Transplant, Budapest, Hungary
19Rikshospitalet, Clinic for Cancer Medicine, Hematology Dept., Section for Stem Cell Transplantation, Oslo University Hospital, Oslo, Norway
20Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Cancer Center and Institute of Oncology, Gliwice, Poland
21The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer , Tel Aviv University, Ramat Gan, Israel
22Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy

Alexandre Bazinet, MD1, Hagop Kantarjian, MD2, Naszrin Arani, MD3*, Uday R Popat, MD4, Courtney D. DiNardo, MD, MSCE1, Naval Daver, MD1, Musa Yilmaz, MD5, Hussein A Abbas, MD, PhD1, Nicholas Short, MD6, Ghayas C. Issa, MD1, Elias Jabbour, MD1, Sherry A. Pierce, BSN, BA1*, Julianne Chen4*, Ricky Garcia7*, Marina Konopleva, MD, PhD6, Guillermo Garcia-Manero, MD6, Amin M Alousi, MD4, Elizabeth J Shpall, MD4, Richard E Champlin, MD4, Gautam Borthakur, MD1, Farhad Ravandi, MD1 and Tapan M. Kadia, MD5

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
3Baylor College of Medicine, Spring, TX
4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
7Department of Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, TX

Razan Mohty, MD1,2, Myriam Labopin, MD3,4,5*, Jean Henri Bouhris6*, Ibrahim Yakoub-Agha, MD, PhD7, Urpu Salmenniemi, MD8*, Anne Huynh9*, Eolia Brissot, MD, PhD10*, Didier Blaise, MD, PhD11, Regis Peffault De Latour12*, Claude-Eric Bulabois, MD13*, Eric Deconinck, MD, PhD14, Jakob Passweg, MD, MS15, Edouard Forcade, MD, PhD16, Hélène Labussière-Wallet, MD17*, Xavier Leleu, MD, PhD18, Anne-Lise Menard, MD19*, Ali Bazarbachi, MD, PhD20, Arnon Nagler, MD21, Fabio Ciceri, MD22* and Mohamad Mohty, MD PhD23

1Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Hematology and Cell Therapy, Hôpital Saint-Antoine, EBMT Paris Study Office, Paris, France
3EBMT Paris study office; Department of Haematology,, Saint Antoine Hospital; INSERM UMR 938, Sorbonne University, Paris, France
4Hematology Department, Hôpital Saint Antoine, Service d'Hématologie Thérapie Cellulaire, Paris, France
5EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
6Stem Cell Transplantation, Institut Gustave Roussy, Villejuif, France
7CHU de Lille, Univ Lille, INSERM U1286, Infinite, Lille, France
8Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
9Département d’Hématologie, CHU-Institut Universitaire du Cancer de Toulouse – Oncopole, Toulouse, France
10Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France
11Hematology Department, Institut Paoli-Calmettes, Marseille, France
12Hopital St. Louis, Department of Hematology - BMT, Paris, France
13Service d'Hématologie, CHU Grenoble Alpes - Université Grenoble Alpes, Grenoble, France
14Hematology department - Inserm UMR 1098, Besançon University Hospital, Besançon, France
15Division of Hematology, University Hospital Basel, Basel, Switzerland
16Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
17Hematology department, Centre Hospitalier Lyon Sud, Pierre Benite, France
18Department of Hematology, CHU Poitiers – Hôpital la Milétrie, Poitiers, France
19Department of Clinical hematology, Centre Henri Becquerel, Rouen, France
20American University of Beirut Dept. of Medicine, Beirut, Lebanon
21Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
22Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
23Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France, Paris, FRA

María Queralt Salas, MD1,2*, Abel Santos Carreira, MD3*, Eshetu G. Atenafu, M.Sc., P.Stat4*, Arjun D. Law, MD5*, Wilson Lam, MD6*, Ivan Pasic7*, Carol Chen8*, Dennis Dong Hwan Kim, MD, PhD9, Fotios V. Michelis7*, Armin Gerbitz9*, Jeffrey H. Lipton6, Rajat Kumar6, Jonas Mattsson7* and Auro Viswabandya, MD, DM10*

1Hematopoietic Transplantation Unit and Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain
2Hans Messner Allogeneic Hematopoietic Cell Transplant Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
3Allogeneic Hematopoietic Cell Transplant Program, Princess Margaret Cancer Center, Toronto, ON, Canada
4Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5University Health Network, Princess Margaret Cancer Centre, Toronto, Canada
6Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada
7Hans Messner Allogenic Transplant Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
8Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Centre, University of Toronto, Ontario, ON, Canada
9Hans Messner Allogeneic Transplant Program, Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
10Princess Margaret Cancer Centre, University of Toronto, Messner Allogeneic Blood and Marrow Transplantation Program, Toronto, ON, Canada

Rohtesh S. Mehta, MD1, Rima M. Saliba, PhD1*, Amin M Alousi, MD1, Gheath Alatrash, PhD, DO2, Qaiser Bashir, MD1, Chitra Hosing, MD1, Partow Kebriaei, MD1, Issa F. Khouri, MD1, Yago Nieto, MD3, Betul Oran, MD, MS4, Uday R Popat, MD1, Muzaffar H Qazilbash, MD1, Jeremy L. Ramdial, MD1, Gabriela Rondon, MD5, Samer A Srour, MD, MS6, Katy Rezvani, MD1, Richard E Champlin, MD1, Elizabeth J Shpall, MD1 and Kai Cao, MS, MD7

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Pearland, TX
3Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
4Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
7Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Alessia Fraccaroli, MD1*, Elena Stauffer1*, Katrin Koch2*, Klaus Hirschbühl, MD3*, Stephan Breitkopf4*, Frank Ziemann, MD1*, Heidrun Drolle5*, Maja Rothenberg-Thurley6*, Annika Maria Dufour, PhD7*, Klaus H. Metzeler, MD1,8, Michael von Bergwelt, Prof. Dr.1*, Karsten Spiekermann9*, Andreas Hausmann, MD10*, Christoph Schmid, MD11*, Mareike Verbeek12*, Tobias Herold, MD1 and Johanna Tischer, MD1*

1Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
2Department of Internal Medicine III, School of Medicine,, University Hospital Rechts der Isar, Technical University of Munich (TUM), 81675 Munich, Germany., Munich, Germany
3Section for Stem Cell Transplantation, University Hospital Augsburg, Augsburg, Germany
4Department of Hematology, Oncology, Immunology, Palliative Care, Munich Clinic Schwabing, Munich, Germany, Munich, Germany
5Department of Medicine III, University Hospital, LMU, Munich, Germany, Munich, Germany
6Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, Ludwig Maximilian University of Munich, Munich, Germany., Munich, Germany
7Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
8Department of Hematology, Cell Therapy and Hemostaseology, University Hospital Leipzig, Leipzig, Germany
9Dept. of Hematology and Oncology, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany
10Department of Hematology, Oncology, Immunology, Palliative Care, Munich Clinic Schwabing, Munich, Germany
11Department of Haematology and Oncology, University Hospital and Medical Faculty Augsburg, Augsburg, Germany
12Department of Internal Medicine III, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany

Sarah Lawless, BSc, FRCPath, MRCP1*, Curly Morris2*, Dirk-Jan Eikema3,4*, Linda Kostner5*, Friedrich Stoelzel, MD6, Nicolaus Kröger, MD7*, Uwe Platzbecker, MD8,9, Wolfgang Bethge, MD10*, Peter Brossart, MD11,12, Renato Fanin, MD13*, Jürgen Finke, MD, PhD14, Jurgen Kuball, MD15, Veronique Leblond, MD, PhD16*, Emma Nicholson, MD, PhD17*, Jakob Passweg, MD, MS18, Daniele Avenoso, PhD19*, Jacques-Olivier Bay, MD, PhD20, Ali Bazarbachi, MD, PhD21, Dolores Caballero, MD22, Joanna Drozd-Sokolowska23*, Christof Scheid24, Donal P. McLornan, MD, PhD25*, Marie Robin, MD, PhD26* and Ibrahim Yakoub-Agha, MD, PhD27

1Belfast City Hospital, Belfast, United Kingdom
2Queens University of Belfast, Belfast, United Kingdom
3EBMT Statistical Unit, Leiden, Netherlands
4Department of Statistics, Leiden University Medical Centre, Leiden, Netherlands
5EBMT Leiden Study Unit, Leiden, Netherlands
6Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany
7University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
8Medical Clinical and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
9Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany
10Hematology & Oncology, Universitaet Tuebingen, Medizinische Klinik, Tuebingen, Germany
11Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, CIO ABCD, Germany
12Department of Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany
13Division of Hematology, Udine University Hospital, Udine, Italy
14Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
15Department of Hematology, UMC Utrecht, Utrecht, Netherlands
16Département d’ Hématologie Hôpital Pitié-Salpêtrière APHP, UPMC Université Paris, Paris, France
17The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
18Division of Hematology, University Hospital Basel, Basel, Switzerland
19Kings College Hospital, London, ENG, GBR
20Department of Hematology and Cell Therapy, Estaing University Hospital, CLERMONT-FERRAND, France
21American University of Beirut Dept. of Medicine, Beirut, Lebanon
22Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
23Central Clinical Hospital, The Medical University of Warsaw, Warsaw, Poland
24Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany
25Department of Haematology, Kings's College Hospital, London, ENG, United Kingdom
26Hopital Saint Louis, APHP, Université de Paris Cité, Paris, FRA
27Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, LILLE, France

Hassaan Yasin, MD1,2*, Mahrukh Naqvi2*, Jongphil Kim, PhD3*, Rawan Faramand, MD4, Omar Alexis Castaneda Puglianini, MD5, Farhad Khimani, MD6, Aleksandr Lazaryan, MD, PhD, MPH7, Taiga Nishihori, MD8, Michael Nieder, MD8*, Joseph Pidala, MD, PhD8 and Nelli Bejanyan, MD6,9

1University of Louisville, Louisville, KY
2Moffitt Cancer Center, Tampa, FL
3Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institutte, Tampa, FL
4Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
5Department of Blood & Marrow Transplant and Cellular Immunotherapy, Vcu-Massey Cancer Center, Tampa, FL
6Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
7Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
8Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL
9Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL

Claire Horgan1*, Khushnuma Mullanfiroze2*, Archana Rauthan2*, Katharine Patrick3*, Naeem Akram Butt4*, Oana Mirci-Danicar, MD4*, Olya O'Connor5*, Caroline Furness5*, Akshay Deshpande6*, Sarah Lawson, MBBS FRCPath7*, Valerie Broderick8*, Pamela Evans9*, Brenda Gibson10*, Wing Roberts11*, Sevasti Galani12*, Amy A. Kirkwood, MSc13*, Beki James14*, Kanchan Rao, MD15*, Persis J Amrolia, MD PhD16* and Robert F Wynn, MD1

1Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester, United Kingdom
2Great Ormond Street Hospital for Children, London, United Kingdom
3Sheffield Childrens NHS Foundation Trust, Sheffield, United Kingdom
4Bristol Royal Hospital for Children, Bristol, United Kingdom
5Royal Marsden Hospital, London, United Kingdom
6Birmingham Children's Hospital, Birmingham, ENG, United Kingdom
7Birmingham Children's Hospital, Birmingham, United Kingdom
8Children’s Health Ireland at Crumlin, Dublin, Dublin 12, Ireland
9Children’s Health Ireland at Crumlin, Dublin, Ireland
10The Royal Hospital for Children, Glasgow, United Kingdom
11Great North Children's Hospital, Newcastle Upon Tyne, United Kingdom
12Cancer Research UK and UCL Cancer Trials Centre University College London, London, United Kingdom
13Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom
14Leeds Children's Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
15Department of Blood and Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom
16Bone Marrow Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom

Alia Cibich, BSc1*, Rakchha Chhetri, MBBS MHID Grad Cert. Biostat.2,3,4*, Kirsty M Sharplin, MBBS4, Naranie Shanmuganathan, MBBS, FRACP, FRCPA2,5,6, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA7,8,9, Deepak Singhal, MBBS, MD, FRACP, FRCPA2,4,8, Ashanka Mahilal Beligaswatte, BA, MBBS, MD, FRACP, FRCPA1, Noemi Horvath, MB ChB FRACP FRCPA1, Philip Selby, B Pharm, MClinPharm10,11*, Leanne Purins, BSc (Hons), PhD12*, Judith Stevens12*, Peter G Bardy, MBBS, FRACP, FRCPA, FRCPath4* and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA2,4,8

1Department of Haematology, Royal Adelaide Hospital, Adelaide, Australia
2Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
3School of Medicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
4Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
5Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
6School of Medicine, University of Adelaide, Adelaide, Australia
7Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
8Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
9Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
10Pharmacy Department, Royal Adelaide Hospital, Adelaide, Australia
11Adelaide Medical School, University of Adelaide, Adelaide, Australia
12Cellular Therapies Laboratory, SA Pathology, Adelaide, Australia

Yimei Feng1*, Lu Wang1*, Ting Chen2*, Han Yao3*, Yun Zhang4*, Yuqing Liu4*, Lu Zhao4*, Lei Gao5*, Peiyan Kong6* and Xi Zhang, MD, PhD2*

1Medical center of hematology, Xinqiao Hospital, Army Medical University, Chongqing, Chongqing, China
2Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
3Xinqiao Hospital, Chongqing, CHN
4Xinqiao hospital, Chongqing, China
5Medical Center of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, People's Republic of China, Chongqing, China
6Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China, Chongqing, China

Andrew H Tam, PharmD, BCOP1*, Aaron C. Logan, MD, PhD2, Angela J Choi, PharmD3*, Richard Fong, PharmD, BCOP1*, Lloyd E. Damon, MD2, Rebecca L. Olin, MD2, Neil Dunavin, MD2, Peter H. Sayre, MD, PhD2, Karin L. Gaensler, MD2, Catherine Smith, MD2 and Lily Yan, PharmD, BCOP1*

1Department of Pharmaceutical Services, University of California, San Francisco, San Francisco, CA
2Division of Hematology and Blood and Marrow Transplantation, University of California, San Francisco, San Francisco, CA
3School of Pharmacy, University of California San Francisco Medical Center, San Francisco, CA

Ali Bazarbachi, MD, PhD1, Myriam Labopin, MD2*, Tobias Gedde-Dahl, MD3*, Péter Reményi, MD4*, Edouard Forcade, MD, PhD5, Nicolaus Kröger, MD6*, Gerard Socie, MD, PhD7, Charles Craddock8, Jean-Henri Bourhis, MD9*, Jurjen Versluis, MD, PhD10*, Ibrahim Yakoub-Agha, MD, PhD11, Urpu Salmenniemi, MD12*, Jean Elcheikh, MD13*, Gesine Bug, MD14*, Jordi Esteve, MD, PhD15*, Arnon Nagler, MD16, Fabio Ciceri, MD17* and Mohamad Mohty, MD PhD18

1American University of Beirut Dept. of Medicine, Beirut, Lebanon
2EBMT Statistical Unit, Sorbonne University, Saint-Antoine Hospital, AP-HP, INSERM UMRs 938, Paris, France
3Rikshospitalet, Clinic for Cancer Medicine, Hematology Dept., Section for Stem Cell Transplantation, Oslo University Hospital, Oslo, Norway
4Department of Haematology and Stem Cell Transplant, Albert, Dél-pesti Centrumkórház –Országos Hematológiai és Infektológiai Intézet, Budapest, Hungary
5Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Hôpital Haut-Leveque, Bordeaux, France
6University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
7Department of Hematology - BMT, Hematology Transplantation, Paris, France
8Department of Haematology, University Hospital Birmingham NHS Trust, Queen Elizabeth Medical Centre, Birmingham, ENG, United Kingdom
9BMT Service, Department of Hematology, Institut Gustave Roussy, Villejuif, France
10Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, MA, Netherlands
11Centre Hospitalier Universitaire de Lille LIRIC, INSERM U1286, Université de Lille, LILLE, France
12Stem Cell Transplantation Unit, HUCH Comprehensive Cancer Center, Helsinki, Finland, Helsinki, Finland
13Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beiurt, Lebanon
14Goethe University Frankfurt, University Hospital, Dept. of Medicine, Hematology and Oncology, Frankfurt, Germany
15IDIBAPS, Hospital Clínic De Barcelona, Barcelona, ESP
16Hematology and Bone Marrow Transplant Unit, Chaim Sheba Medical Center, Tel Hashomer, Israel
17Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
18EBMT Paris study office / CEREST-TC, Paris, France, Department of Hematology, Saint Antoine Hospital, Paris, France, INSERM UMR 938, Sorbonne University, Paris, France

*signifies non-member of ASH